Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs

Cell Stem Cell
Tushar MenonInder M Verma

Abstract

X-linked Severe Combined Immunodeficiency (SCID-X1) is a genetic disease that leaves newborns at high risk of serious infection and a predicted life span of less than 1 year in the absence of a matched bone marrow donor. The disease pathogenesis is due to mutations in the gene encoding the Interleukin-2 receptor gamma chain (IL-2Rγ), leading to a lack of functional lymphocytes. With the leukemogenic concerns of viral gene therapy there is a need to explore alternative therapeutic options. We have utilized induced pluripotent stem cell (iPSC) technology and genome editing mediated by TALENs to generate isogenic subject-specific mutant and gene-corrected iPSC lines. While the subject-derived mutant iPSCs have the capacity to generate hematopoietic precursors and myeloid cells, only wild-type and gene-corrected iPSCs can additionally generate mature NK cells and T cell precursors expressing the correctly spliced IL-2Rγ. This study highlights the potential for the development of autologous cell therapy for SCID-X1 subjects.

References

Jun 8, 1999·Annual Review of Immunology·C A BironT P Salazar-Mather
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Dec 5, 2002·International Journal of Hematology·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Nov 15, 2007·Stem Cells and Development·I-Ting KaoShiaw-Min Hwang
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Jan 27, 2009·Current Opinion in Microbiology·Sabine Kay, Ulla Bonas
Nov 26, 2009·Science·Matthew J Moscou, Adam J Bogdanove
Jun 24, 2010·Current Opinion in Plant Biology·Adam J BogdanoveThomas Lahaye
Jan 8, 2011·Science·Eric VivierSophie Ugolini
Jul 9, 2011·Nature Biotechnology·Dirk HockemeyerRudolf Jaenisch
Apr 10, 2013·Gene·Sayandip Mukherjee, Adrian J Thrasher
Aug 24, 2013·Science·Inder M Verma
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Amy L FirthInder M Verma
May 30, 2014·Nature·Pietro GenoveseLuigi Naldini
Oct 9, 2014·The New England Journal of Medicine·Salima Hacein-Bey-AbinaAdrian J Thrasher

❮ Previous
Next ❯

Citations

Jan 15, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Versha PrakashRafael J Yáñez-Muñoz
Sep 19, 2015·Critical Reviews in Oncology/hematology·Stijn Vanhee, Bart Vandekerckhove
Oct 8, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Li B LiDavid W Russell
Jun 28, 2016·International Journal of Molecular Sciences·Sylvia Merkert, Ulrich Martin
Oct 11, 2016·Trends in Cancer·Julian GingoldDung-Fang Lee
Oct 30, 2016·Trends in Immunology·Patrick M BrauerJuan Carlos Zúñiga-Pflücker
Feb 9, 2017·Cells·Nicholas BrookhouserDavid A Brafman
Mar 9, 2018·Molecular Biotechnology·Minjung Song, Suresh Ramakrishna
Oct 18, 2018·Physiological Reviews·Peter KaragiannisKenji Osafune
Oct 10, 2018·Current Opinion in Allergy and Clinical Immunology·Caroline Y Kuo
Jan 5, 2017·The Korean Journal of Internal Medicine·Eun Ji KimJi Hyeon Ju
Apr 11, 2019·Nature Communications·Mara Pavel-DinuMatthew H Porteus
Aug 14, 2020·American Journal of Physiology. Cell Physiology·Kalpaj R ParekhAmy L Ryan
Aug 16, 2016·Blood·María L Toribio
Jun 14, 2019·Stem Cells International·Methichit Wattanapanitch
Jun 7, 2019·Disease Models & Mechanisms·Maria Georgomanoli, Eirini P Papapetrou
Nov 18, 2020·Stem Cell Research & Therapy·Mohsen EbrahimiMaryam Farzaneh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

The New England Journal of Medicine
Salima Hacein-Bey-AbinaM Cavazzana-Calvo
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
C BaumA Thrasher
© 2021 Meta ULC. All rights reserved